OriGene

ERCC1 Monoclonal Antibody (4F9), UltraMAB™

Advanced Verification

This Antibody was verified by Knockout to ensure that the antibody binds to the antigen stated.

6 References

View all (85) ERCC1 antibodies

Datasheet

Protocols

Questions & Answers

Tech Support

Datasheet

Protocols

Questions & Answers

Tech Support

Product Image Gallery

ERCC1 Antibody in Immunocytochemistry (ICC/IF) — Immunofluorescent staining of HeLa cells using anti-ERCC1 mouse monoclonal antibody (UM500008, green, 1:100). Actin filaments were labeled with Alexa Fluor 594 Phalloidin (red), and nuclear with DAPI (blue). Scale bar, 20µm.

ERCC1 Antibody in Immunohistochemistry (Paraffin) (IHC (P)) — Immunohistochemical staining of FFPE normal adjacent lung from tumor specimen using heat-induced epitope retrieval HIER at 120°C for 3min with Accel buffer pH8.7, mouse monoclonal antibody anti-ERCC1 clone 4F9 was used at 1 µg/mL. Strong nuclear stain in lung pneumocytes and macrophages.

ERCC1 Antibody in Western Blot (WB) — Equivalent amounts of cell lysates (10 µg per lane) of wild-type Hela cells (WT, Cat# LC810HELA) and ERCC1-Knockout Hela cells (KO, Cat# LC810072) were separated by SDS-PAGE and immunoblotted with anti-ERCC1 monoclonal antibody UM500008. Then the blotted membrane was stripped and reprobed with anti-HSP90AB1 antibody (TA500494) as a loading control. (1:500)

ERCC1 Antibody in Peptide array (ARRAY) — OriGene overexpression protein microarray chip was immunostained with UltraMAB anti-ERCC1 mouse monoclonal antibody (Clone 4F9). The positive reactive proteins are highlighted with red arrows in the enlarged subarray. Other positive controls spotted in this subarray are serial dilutions of mouse IgG as controls.

ERCC1 Antibody — Antibody specificity was demonstrated by CRISPR-Cas9 mediated knockout of target protein. Loss of signal was observed for target protein in ERCC1 knockout (KO) Hela cell line using Anti-ERCC1 monoclonal antibody (Product # UM500008). {KO}

Product Details

UM500008

Applications	Tested Dilution	Publications
Western Blot (WB)	1:2,000	-
Immunohistochemistry (Paraffin) (IHC (P))	1:50	-
Immunocytochemistry (ICC/IF)	1:100	-
Miscellaneous PubMed (Misc)	-	View 6 publications 6 publications

Product Specifications
Species Reactivity	Human
Published species	Not Applicable
Host/Isotype	Mouse / IgG1
Class	Monoclonal
Type	Antibody
Clone	4F9
Immunogen	Protein expressed in 293T cell transfected with human ERCC1 expression vector View immunogen
Conjugate	Unconjugated
Form	liquid
Concentration	0.5-1.0 mg/mL
Purification	Affinity chromatography
Storage buffer	PBS with 1% BSA, 50% glycerol
Contains	0.02% sodium azide
Storage conditions	-20° C, Avoid Freeze/Thaw Cycles

Target Information

ERCC1 is a non-catalytic component of a structure-specific DNA repair endonuclease responsible for the 5'-incision during DNA repair. It is responsible, in conjunction with SLX4, for the first step in the repair of interstrand cross-links (ICL). It participates in the processing of anaphase bridge-generating DNA structures, which consist in incompletely processed DNA lesions arising during S or G2 phase, and can result in cytokinesis failure. ERCC1 is also required for homology-directed repair (HDR) of DNA double-strand breaks, in conjunction with SLX4. (Uniprot)

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

Product References

A novel antibody-based approach to detect the functional ERCC1-202 isoform.

DNA repair

Kuo MS,Adam J,Dorvault N,Robin A,Friboulet L,Soria JC,Olaussen KA

Sun Apr 01 00:00:00 EDT 2018

ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas.

European journal of endocrinology

Laufs V,Altieri B,Sbiera S,Kircher S,Steinhauer S,Beuschlein F,Quinkler M,Willenberg HS,Rosenwald A,Fassnacht M,Ronchi CL

Thu Feb 01 00:00:00 EST 2018

Development and Validation of an ERCC1 Immunohistochemistry Assay for Solid Tumors.

Archives of pathology & laboratory medicine

Bahamon BN,Gao F,Danaee H

Thu Dec 01 00:00:00 EST 2016

Measuring ERCC1 protein expression in cancer specimens: validation of a novel antibody.

Scientific reports

Smith DH,Fiehn AM,Fogh L,Christensen IJ,Hansen TP,Stenvang J,Nielsen HJ,Nielsen KV,Hasselby JP,Brünner N,Jensen SS

Fri Mar 07 00:00:00 EST 2014

ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial.

British journal of cancer

Bauman JE,Austin MC,Schmidt R,Kurland BF,Vaezi A,Hayes DN,Mendez E,Parvathaneni U,Chai X,Sampath S,Martins RG

Tue Oct 15 00:00:00 EDT 2013

Using protein microarray technology to screen anti-ERCC1 monoclonal antibodies for specificity and applications in pathology.

BMC biotechnology

Ma D,Baruch D,Shu Y,Yuan K,Sun Z,Ma K,Hoang T,Fu W,Min L,Lan ZS,Wang F,Mull L,He WW

Wed Nov 21 00:00:00 EST 2012

Bioinformatics

Protein Aliases: DNA excision repair protein ERCC-1; excision repair cross-complementation group 1; excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)

Gene Aliases: COFS4; ERCC1; RAD10; UV20

UniProt ID: (Human) P07992

Entrez Gene ID: (Human) 2067

Molecular Function: endodeoxyribonuclease